Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | GRM8 | O00222 | 1/20 | 0.52 |
| ▸ | GRM6 | O15303 | 1/20 | 0.52 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.52 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.52 |
| ▸ | GSR | P00390 | 1/20 | 0.52 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.52 |
| ▸ | GRM5 | P41594 | 1/20 | 0.52 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.52 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.52 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.52 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.52 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.52 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.52 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.52 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.52 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.52 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.52 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6740146 | 1.00 | CYP1A2 (0.52) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL561334 | 1.00 | CYP1A2 (0.52) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| Hydrochloric Acid SCHEMBL3580142 | 0.98 | CYP1A2 (0.50) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| Hydrochloric Acid SCHEMBL2124740 | 0.98 | CYP1A2 (0.50) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| Hydrochloric Acid SCHEMBL2124734 | 0.98 | CYP1A2 (0.50) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL28096244 | 0.98 | CYP1A2 (0.50) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL15888382 | 0.90 | GABRP (0.41) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL30439764 | 0.89 | ENPEP (0.43) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL2218974 | 0.89 | ENPEP (0.43) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| Aminocaproic Acid SCHEMBL5709467 | 0.87 | LMNA (0.50) | CYP1A2GRM8GRM6GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 719 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289842-A1 | Processes for Making NAG-25, a Carbohydrate Targeting Moiety, and its Intermediates | AMGEN INC. | 2025-09-18 | — | — | US | claimed |
| CN-119350469-B | Method for synthesizing CAGRILINTIDE by large fragment SPPS-LPPS mixing method | 杭州诺澳生物医药科技有限公司 | 2025-05-23 | — | — | CN | claimed |
| WO-2025094036-A1 | A PROCESS FOR THE PREPARATION OF LIRAGLUTIDE | PIRAMAL PHARMA LIMITED (IN) | 2025-05-08 | — | — | WO | claimed |
| EP-4532531-A1 | PROCESS FOR PREPARING GLUCAGON-LIKE PEPTIDE-1 | ScinoPharm Taiwan, Ltd. (TW) | 2025-04-09 | — | — | EP | claimed |
| CN-119708196-A | Tenipout peptide synthesis method | 深圳翰宇药业股份有限公司 | 2025-03-28 | — | — | CN | claimed |
| WO-2025052429-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF TIRZEPATIDE | NEULAND LABORATORIES LIMITED (IN) | 2025-03-13 | — | — | WO | claimed |
| EP-4519278-A1 | PROCESSES FOR MAKING NAG-25, A CARBOHYDRATE TARGETING MOIETY, AND ITS INTERMEDIATES | Amgen Inc. (US) | 2025-03-12 | — | — | EP | claimed |
| CN-119139157-B | Hair loss preventing and caring component, preparation method thereof and shampoo | 广州市圣莎拉化妆品有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119562958-A | Methods for preparing NAG-25 carbohydrate targeting moieties and intermediates thereof | 安进公司 | 2025-03-04 | — | — | CN | claimed |
| CN-118772035-B | Method for efficiently preparing fatty diacid derivative and application thereof | 合肥亿帆生物制药有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-101955515-A | Progesterone releasing hormone-methotrexate compound and pharmaceutical application thereof | UNIV CHONGQING MEDICAL | 2011-01-26 | — | — | CN | claimed |
| EP-0737197-B1 | AMINO ALKANOIC ESTERS OF RAPAMYCIN | AMERICAN HOME PROD (US) | 2002-05-08 | — | — | EP | claimed |
| EP-1171149-A1 | INHIBITION OF PROTEASOME FUNCTION INDUCES PROGRAMMED CELL DEATH IN ENDOTHELIAL CELLS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2002-01-16 | — | — | EP | claimed |
| EP-1053750-A1 | Use of proteasome-inhibitor for the induction of programmed cell death (apoptosis) | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2000-11-22 | — | — | EP | claimed |
| WO-2000064467-A1 | INHIBITION OF PROTEASOME FUNCTION INDUCES PROGRAMMED CELL DEATH IN ENDOTHELIAL CELLS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2000-11-02 | — | — | WO | claimed |
| JP-H09507236-A | — | — | 1997-07-22 | — | — | JP | claimed |
| EP-0737197-A1 | AMINO ALKANOIC ESTERS OF RAPAMYCIN | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-10-16 | — | — | EP | claimed |
| WO-1995018133-A1 | AMINO ALKANOIC ESTERS OF RAPAMYCIN | AMERICAN HOME PRODUCTS CORPORATION (US) | 1995-07-06 | — | — | WO | claimed |
| US-5389639-A | Immunosuppressants | AMERICAN HOME PRODUCTS COMPANY (US) | 1995-02-14 | — | — | US | claimed |
| EP-0294294-A2 | Amine derivatives of anthracycline antibiotics | CYTOGEN CORPORATION (US) | 1988-12-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289842-A1 | Processes for Making NAG-25, a Carbohydrate Targeting Moiety, and its Intermediates | ENGASE, MAN2B2, GALNT2 | CYP1A2 4771/4885GRM8 3513/4885GRM6 3569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.